Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 60.71M | $ 29.69M | $ 0 | -48.9% |
3/31/2025 | $ 56.59M | $ 10.89M | $ 0 | -19.24% |
12/31/2024 | $ 56.32M | $ 14.24M | $ 0 | -25.29% |
9/30/2024 | $ 95.03M | $ 19.96M | $ 0 | -21% |
6/30/2024 | $ 30.16M | $ 14.72M | $ 0 | -48.82% |
3/31/2024 | $ 93.15M | $ 16.83M | $ 0 | -18.06% |
12/31/2023 | $ 91.94M | $ 13.86M | $ 0 | -15.08% |
9/30/2023 | $ 110.55M | $ 35.48M | $ 0 | -32.09% |
6/30/2023 | $ 160.96M | $ 29.89M | $ 0 | -18.57% |
3/31/2023 | $ 209.41M | $ 38.9M | $ 0 | -18.58% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for CUE BIOPHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 92.86M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 350.62M ]
(=) Payout Yield [ -26.49% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |